Mechanism of Vascular Toxicity in Rats Subjected to Treatment with a Tyrosine Kinase Inhibitor

Sunitinib (Su) is a tyrosine kinase inhibitor with antiangiogenic and antineoplastic effects that is recommended therapy for renal cell carcinoma, gastrointestinal stromal tumors, and pancreatic neuroendocrine tumors. Arterial hypertension is one of the adverse effects observed in the treatment with...

Descripción completa

Detalles Bibliográficos
Autores principales: Reyes-Goya, Claudia, Santana-Garrido, Álvaro, Soto-Astacio, Estefanía, Aramburu, Óscar, Zambrano, Sonia, Mate, Alfonso, Vázquez, Carmen M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7560282/
https://www.ncbi.nlm.nih.gov/pubmed/32698382
http://dx.doi.org/10.3390/toxics8030049

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7560282/
https://www.ncbi.nlm.nih.gov/pubmed/32698382
http://dx.doi.org/10.3390/toxics8030049

Ejemplares similares